新生儿呼吸衰竭ECMO支持中的正性肌力药需求
该单中心回顾性研究纳入2010至2016年因原发性呼吸衰竭接受ECMO的110例新生儿,评估ECMO模式对正性肌力药需求(VIS评分)的影响及高需求是否预测死亡。结果显示VV ECMO占87%,即使插管前VIS较高也可成功管理;ECMO后24小时VIS在非存活者中显著更高,且拔管时差异更显著。
要点
- 呼吸衰竭新生儿即使插管前VIS较高,仍可成功应用VV ECMO管理。
核心结论
- 呼吸衰竭新生儿即使正性肌力药需求较高,仍可成功采用VV ECMO管理。
- ECMO支持24小时后的血管活性药物需求可预测死亡。
研究设计与样本
- 单中心回顾性病历审查,纳入2010至2016年因原发性呼吸衰竭接受ECMO的所有新生儿。
- 共识别110例新生儿,其中96例(87%)接受VV ECMO,11例(10%)接受VA ECMO,3例(3%)从VV转为VA。
- 采用文献所述方法计算血管活性正性肌力评分(VIS),数据分析使用描述性统计和单因素分析。
主要发现
- 两组VIS在ECMO开始后4小时内均显著下降。
临床怎么用
- 对呼吸衰竭新生儿接受ECMO时,可考虑VV模式即使插管前正性肌力药需求较高。
- ECMO支持24小时后应关注VIS变化,持续高VIS提示死亡风险增加。
局限性
- 单中心回顾性研究,样本量有限(110例),仅接受单因素分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate how inotropic requirements in neonates with respiratory failure are affected by extracorporeal membrane oxygenation (ECMO) mode and whether high requirements predict mortality. STUDY DESIGN: This retrospective chart review included all neonates undergoing ECMO for primary respiratory failure from 2010 to 2016 at a single institution. The vasoactive inotropy score (VIS) was calculated as described in the literature. Data were analyzed with descriptive statistics and univariate analyses. RESULTS: Of the 110 identified neonates, 96 underwent venovenous (VV) (87%), 11 (10%) venoarterial, and 3 (3%) converted from VV to venoarterial. The median precannulation VIS score was 33.02 for patients who underwent VV compared with 28.93 for venoarterial (P = .25) and 15 for infants converted. VIS decreased dramatically by 4 hours of ECMO in both groups. The VIS before cannulation was similar in survivors and nonsurvivors, but was significantly higher in nonsurvivors after 24 hours of ECMO (median VIS, 12 [IQR, 8-25] vs 8 [IQR, 3.0-14.5]; P = .035) and at decannulation (10 [IQR, 7-19] vs 3 [IQR, 0-7]; P < .001). CONCLUSIONS: Neonates with respiratory failure can be successfully managed on VV ECMO even with considerable vasoactive requirements. Vasoactive requirement after 24 hours of ECMO was predictive of mortality.
引用
- Sewell EK, Piazza AJ, Davis J, et al. Inotrope Needs in Neonates Requiring Extracorporeal Membrane Oxygenation for Respiratory Failure. J Pediatr. 2019. PMID: 31443896. doi:10.1016/j.jpeds.2019.07.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。